Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-26-162766
Filing Date
2026-04-20
Accepted
2026-04-20 08:02:10
Documents
1
Period of Report
2026-04-20

Document Format Files

Seq Description Document Type Size
1 6-K d620541d6k.htm 6-K 10212
  Complete submission text file 0001193125-26-162766.txt   11290
Mailing Address TUBORG BOULEVARD 12 HELLERUP Denmark
Business Address TUBORG BOULEVARD 12 HELLERUP Denmark 45 70 22 22 44
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 26873399
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)